Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Dichlorphenamide

A carbonic anhydrase inhibitor of the sulfonamide family, approved in the United States in 1958 to treat glaucoma; it later proved useful in some treatment-resistant epilepsies as well. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?Nearly forgotten after newer glaucoma drugs arrived, it was reborn in 2015 as an orphan drug for primary periodic paralysis, rare disorders in which the muscles weaken in episodes.

DichlorphenamideGo to the active ingredient →

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.